Below is a link to view the latest entry from the monthly Law360 that we publish relating to healthcare private equity investments. This column was written by Geoff C. Cockrell, Amber McGraw Walsh and Richard S. Grant, McGuireWoods LLP.
We … Continue Reading
Most investors have likely heard about the King v. Burwell case, which addresses whether language in the Affordable Care Act allows the government to provide healthcare insurance subsidies to people across the country or only in those states with their … Continue Reading
BDO Consulting has published an interesting infographic we think healthcare investors may be interested in.
The infographic focuses on “navigating e-discovery in the healthcare datasphere.” It provides four questions providers (as well as legal counsel) should consider when preparing for … Continue Reading
Invuity has announced it has raised $20 million in equity.
Invuity, headquartered in San Francisco, is a surgical photonics company that develops devices to provide visualization of the surgical cavity. Clinical applications include breast and thyroid oncology, plastics, spine, … Continue Reading
Below is a link to view the latest entry from the monthly Law360 that we publish relating to healthcare private equity investments. This column was written by Geoff C. Cockrell, Amber McGraw Walsh and William T. Nash, McGuireWoods LLP.
Concierge … Continue Reading
An analysis by Accenture of the State Health Innovation Plans developed by 25 states found the top five projected investment areas of the states currently participating in the program.
Information like this can give investors valuable insights into areas of … Continue Reading
Investments by the federal government in medical research has declined in recent years, according to the results of a new study published in the Journal of the American Medical Association.
U.S. funding had increased 6% per year from 1994-2004, … Continue Reading
Novartis Pharmaceuticals has announced it has formed a joint investment company with Qualcomm Ventures, the venture investment group of Qualcomm.
The company — dRx Capital AG — will invest up to $100 million to support early stage digital health companies.… Continue Reading
Vascular Dynamics has announced it has secured $16.85 million in series B financing.
Vascular Dynamics, headquartered in Mountain View, Calif., provides minimally invasive solutions for the treatment of refractive or resistant hypertension.
This round of financing was led by … Continue Reading
Medgadget has come out with its list of the best medical technologies of 2014.
They are as follows:
… Continue Reading
- Flexible Microelectronics
- 3D Printing in Medicine
- Smart Powered Prostheses
- XStat Rapid Hemostasis System
- Diabetes Monitoring/Glucose Control
- Radiological Imaging Equipment (“The Big Stuff”)
Assurex Health has announced it has secured $30 million in equity financing.
Assurex, headquartered in Mason, Ohio, is a personalized medicine company specializing in helping physicians determine the right medication for individual patients with behavioral health disorders.
Participants in … Continue Reading
CardioDx has announced it has secured $35 million in total equity financing.
CardioDx, headquartered in Redwood City, Calif., is a molecular diagnostics company specializing in cardiovascular genomics.
Participants in this round of financing included Alberta Investment Management Corp. and … Continue Reading
Last week we published an article discussing the nuances of investing in a healthcare business with heavy “out-of-network” reimbursement. We get a lot of questions from funds and lenders on this topic as such investments involve very specific regulatory and … Continue Reading
Direct Flow Medical has announced it closed a new round of financing totaling $32 million.
Direct Flow Medical, headquartered in Santa Rosa, Calif., is a developer of transcatheter heart valve technologies.
The financing rounds includes $17 million in PE, … Continue Reading
A new study conducted by management consulting firm A.T. Kearney identifies five disruptive forces that could cost the medical device industry $34 billion over the next five years.
For the study, titled “Medical Devices: Equipped for the Future?,” A.T. Kearney … Continue Reading
Earlier this month, Flowonix Medical announced it had obtained debt and equity financing totaling approximately $40 million.
Flowonix, headquartered in Mt. Olive, N.J., is focused on providing implantable drug delivery solutions and has developed an implantable drug pump designed … Continue Reading
Baird Capital has announced the final close of its fourth venture capital fund with a total of $185 million in committed capital.
This figure exceeds Baird’s original goal of $150 million and the size of its previous fund ($171 million, … Continue Reading
Monteris Medical has announced it has secured $30 million in series B financing.
Monteris, headquartered in Plymouth, Minn., is a developer of minimally invasive laser systems for the ablation of pathologic brain lesions such as primary and metastatic tumors.… Continue Reading
Private equity investors continue to be active investors in the dialysis industry, as we’ve frequently discussed in the past, including in the Law360 report on “Private Equity Interest in the Dialysis Sector Continues to Thrive” that can be accessed here… Continue Reading
For the many investors who remain interested in dental practice management (DPM) businesses, we are sharing here a white paper authored by myself and our McGuireWoods colleagues Holly Carnell and Amanda Enyeart titled “7 Key Lessons for Dental Practice Management … Continue Reading
Every fall, the OIG publishes its Work Plan for the coming year. The Work Plan can provide useful insight into the specific area of enforcement for the OIG, which can help investors and companies better assess risk.
Our McGuireWoods colleagues … Continue Reading
DaVita Healthcare Partners has agreed to pay $350 million to resolve claims it violated the False Claims Act, according to a Department of Justice press release.
DaVita, which is based in Denver and has dialysis clinics in 46 states … Continue Reading
VytronUS has announced it has secured $31.6 million in an oversubscribed series B financing.
VytronUS, based in Sunnyvale, Calif., is a medical device company developing technologies for the treatment of cardiac arrhythmias.
The financing round was led by Apple … Continue Reading
Invitae Corp. has announced it has raised $120 million in series F financing.
Invitae, based in San Francisco, is a genetic information company specializing in genetic diagnostics for hereditary disorders.
New investors participating in the round included The Broe … Continue Reading